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Introduction
The 2014 World Anti-Doping Agency (WADA) Prohibited 
List shows testosterone and epitestosterone listed as class S1.1a and 
S1.1b, with its use banned in and out of competition [1]. Doping 
with testosterone is suspected if the urinary ratio of testosterone over 
epitestosterone (T/E) exceeds 4 [2]. According to the 2012 (WADA) 
laboratory statistics, elevated testosterone based on the testosterone 
over epitestosterone (T/E) ratio accounts for 55.5% of atypical 
findings within the anabolic agents’ drug class from a total of 2,279 
for all anabolic agents, which constitute half of all adverse and atypical 
findings [3]. This T/E ratio approach to testing for testosterone abuse 
is only accurate if testosterone and epitestosterone are metabolised at 
the same rate and no other external factors or inter individual factors 
would alter the metabolism of these steroids [4]. 
One of the major metabolic pathways in testosterone and 
epitestosterone regulation and elimination is by glucuronidation 
through addition of glucuronic acid by UDP-glucuronosyltransferase 
(UGT) enzymes for excretion in urine. Variations in enzyme 
preference are observed with UGT 2B17 predominating for 
testosterone glucuronidation, whilst UGT2B7 is the most active UGT 
for epitestosterone glucuronidation [5]. A variety of effectors of steroid 
UGT glucuronidation have been identified, including pharmacogenetic 
variations resulting in different UGT2B17 expression which affects the 
urinary T/E ratios [6-8]. A number of in vitro studies have identified 
small molecule inhibitors of UGT2B17 and other UGTs toward 
testosterone metabolism. These inhibitors include non-steroidal 
anti-inflammatory drugs diclofenac and ibuprofen [5], flavonoids 
commonly found in red wine [9] and catechins in green and white 
tea [10]. As doping tests for testosterone abuse involve deconjugation 
by β-glucuronidase to determine total urinary T/E ratios, the doping 
test could be affected by the inhibitory effects of pharmaceuticals and 
dietary components. Inhibition of testosterone glucuronidation could 
lead to an increase in testosterone in serum leading to potential adverse 
health effects. Extending these potentially significant in vitro results to 
in vivo, experimentation calls for a streamlined analytical procedure 
that caters for analysing multiple biological samples, such as urine and 
blood without introducing intra-method variances owing to different 
sensitivity and specificity.
This report describes a method to determine testosterone 
and epitestosterone levels in rat serum and urine using liquid 
chromatography tandem mass spectrometry (LC-MS/MS). Rat models 
have a number of advantages for controlled clinical trials, including 
standardised conditions and diet, and testosterone is glucuronidated 
by phase 2 metabolism as is in humans [11,12]. This method could be 
applied to such rat studies, where the measurement of testosterone and 
epitestosterone in these matrices are required through the duration of 
study.
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Abstract
Testosterone and epitestosterone are mainly excreted as glucuronides. The aim of this study was to develop and 
validate a method using liquid chromatography tandem mass spectrometry (LC-MS/MS) to analyse testosterone and 
epitestosterone in rat serum and urine to assist in vivo studies on steroid metabolism. The method was developed by 
spiking charcoal stripped rat plasma and urine with the analytes. The developed method was then applied to serum 
(n=6) and urine samples (n=6) from young male brown Norway rats to determine testosterone and epitestosterone 
concentrations. The assay showed linearity within quantification range coefficient (r2) values above 0.991. Optimum 
conditions were determined for the deconjugation of glucuronidated testosterone and epitestosterone along with the 
internal standard stanozolol D3. Accuracy, precision and extraction recovery for both compounds was satisfactory 
in both matrices. The method was capable of quantifying 0.250 ng/mL concentrations of testosterone and 
epitestosterone in 100 µL of serum and urine. The average concentrations of free and deconjugated testosterone 
and epitestosterone found in the rat samples were: urine–201.68 ± 90.16 ng/mL and 85.37 ± 21.20 ng/mL; serum– 
363.40 ± 11.615 ng/mL and 1.75 ± 0.118 ng/mL, respectively. This method is sensitive, specific and reproducible for 
the determination of free and deconjugated testosterone and epitestosterone in rat serum and urine. The method can 
be used for in vivo analysis for further investigations of testosterone and epitestosterone concentrations in studies 
monitoring endocrine dysfunctions and doping. 
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Materials and Methods
Chemicals
Reference standards for testosterone and epitestosterone and 
testosterone glucuronide were purchased from Sigma Aldrich (Poole, 
UK). Epitestosterone glucuronide and stanozolol D3 (internal 
standard) were purchased from LGC Standards (Teddington, UK). All 
reference materials had a purity ≥ 98%. Sodium hydrogen phosphate 
heptahydrate, sodium phosphate monobasic dehydrate, HPLC grade 
pentane and LCMS grade acetonitrile and water were purchased 
from Sigma Aldrich (Poole, UK). β-Glucuronidase from E. coli (Cat 
No. 03707598001, Lot No. 13931722) was purchased from Roche 
Diagnostics (Burgess Hill, UK). Rat 4x charcoal stripped 0.2 µ filtered 
plasma and urine was purchased from Sera Laboratories. A SB C-18 
column (2.1 mm, 50 mm, 1.8 µm) and 0.2 µm inline filter was purchased 
from Agilent (Stockport, UK). Syringe driven 0.2 µm PTFE filters were 
purchased from Millipore (Watford, UK). Silanized glass vials where 
purchased from Sigma Aldrich (Poole, UK).
Animals and samples
Urine samples were obtained from six male, brown Norway rats 
(weighing 280-340 g) as part of an independent study [13], purchased 
from Charles River laboratories (Sulzfeld, Germany). Rats were kept 
under the conditions and urine samples were collected as described 
previously [13]. Water and food was available ad libitum. Normal 
serum samples from six male brown Norway rats were purchased 
from Sera Laboratories. These rats where approximately 11-12 weeks 
old weighting between 250-275 g. The serum and urine samples were 
thawed at 37°C and vortex mixed. Aliquots (100 µL) were taken from 
each sample for analysis.
Enzyme hydrolysis of testosterone and epitestosterone gluc-
uronide
The enzyme β-glucuronidase was used to deconjugate the 
glucuronide conjugates for the determination of total (glucuronide 
conjugated+unconjugated) concentration of testosterone and 
epitestosterone in serum and urine.
Sample purification
Liquid-liquid extraction was performed using pentane. The mixture 
was vortex mixed in a glass centrifuge for 20 seconds and centrifuged 
at 3220×g for 10 minutes at 4°C. The organic layer was transferred to a 
salinized vial and evaporated under incubation at 40°C using a gentle 
stream of compressed air. The sample were then reconstituted with 100 
µL of acetonitrile and filtered through a 0.2 micron PTFE membrane 
filter for analysis by LC-MS/MS.
Liquid chromatographic-tandem mass spectrometry
Testosterone and epitestosterone analyses were carried out based 
on a previous method [14], with modifications, using an LC-MS/MS 
system comprised of a 1260 infinity LC system (Agilent, Workingham, 
UK) coupled to a 6430 triple quadruple mass spectrometer (Agilent, 
Workingham, UK). The LC system comprised of a binary pump, 
automatic degasser, column heater and 1290 infinity thermostated 
autosampler. Compounds were separated using a SB C-18 column 
(2.1 mm, 50 mm, 1.8 µm) that was heated to 45°C. An inline filter 0.2 
micron was used to prevent the analytical column from blocking. The 
mobile phase consisted of water (solvent A) and acetonitrile (solvent B) 
with the gradient as follows: 0-5 min (53% A: 47% B), 5-9 min (53% A: 
47% B), 9-11 min (0% A: 100% B), 11-25 min (53% A: 47% B). The flow 
rate was 250 µL/min and the injection volume was 4 µL. 
The mass spectrometer was set using electrospray ionisation (ESI) 
operated in positive ion mode. The protonated molecules, [M+H]+, of 
testosterone and epitestosterone (m/z 289.3) and stanozolol D3 (m/z 
332.5) were used as precursor ions for collision induced dissociation 
(CID) for MS-MS analysis. Multiple reactions monitoring (MRM) 
mode was used to monitor the precursor ions and diagnostic product 
ions for each analyte and internal standard based on a previous 
method [14]. Table 1 details the MRM transitions, collision energy and 
retention times of testosterone, epitestosterone and stanozolol D3.
The mass spectrometer parameter optimisation was performed 
using Masshunter optimizer software (version B.03.01). The conditions 
applied for optimum ionisation were capillary voltage 4000 V, drying 
gas temperature 325°C, drying gas flow rate 10 L/min, nebulising 
gas pressure 35 psi and fragmentor voltage of 100 V. Masshunter 
workstation software (LC/MS data acquisition, version B.03.01) was 
used to control the LC-MS/MS system.
Method validation
Validation was performed in accordance with Food and Drug 
Administration (FDA) guidelines to establish sensitivity, specificity, 
selectivity, linearity, limit of detection, inter and intraday precision 
and accuracy, percentage recoveries, deconjugation and matrix effects. 
Steroid free rat plasma and urine were used for method validation.
Calibration curves of known standards were prepared by 
spiking charcoal-stripped plasma and urine with testosterone 
and epitestosterone and the internal standard (IS) stanozolol D3. 
Quality controls (QC) were prepared in the same manner over four 
concentration ranges of the calibration curve. The calibration curve 
was plotted for testosterone and epitestosterone levels in plasma and 
urine by using the analyte to IS ratio. The linearity of the calibration 
curve was determined using linear analysis.
The accuracy of the method was determined using replicate (N=6, 
per concentration level) QC samples at four concentration levels and 
comparing the mean calculated values to the nominal concentration 
values. Intra-day precision was determined by analysing the six 
replicated at each concentration level in one day and inter-day precision 
was performed by analysing 6 replicates at each concentration level 
over three consecutive days. The relative standard deviation (RSD 
%) was used for characterising precision. For the three concentration 
ranges, an acceptable variability was set at 15%, for the lower limit of 
quantification (LLOQ) this was set at 20%. LLOQ was determined as 
the lowest concentration of the analyte that gave a peak response which 
could be measured with precision and accuracy (RSD less than 20%).
The absolute extraction recoveries of testosterone and 
epitestosterone were determined by analysing a blank matrix of plasma 
and urine that was spiked with a known concentration of analyte and IS 
that had been extracted with standard solutions prepared in acetonitrile 
at the same concentrations. The peak area ratios were compared at four 
Compounds Retention Time 
(min)
MRM transitions Collision energy 
(eV)
Testosterone 8.6 289.2>109 22
289.2>97 26
Epitestosterone 10.58 289.2>109 21
289.2>97 25
Stanozolol D3 11.64 332.2>81.2 50
Table 1: Analytical parameters for LC and MS.
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concentration levels using six replicate samples at each concentration 
for the extracted and neat samples.
To analyse any effect of the matrix, blank plasma and urine were 
extracted and then spiked with known concentrations of testosterone, 
epitestosterone and IS, for comparison to a standard solution at 
equivalent concentrations in acetonitrile. These samples were prepared 
over four concentration ranges using replicates of six samples.
To assess the deconjugating activity of β-glucuronidase, the 
enzyme was incubated with standard concentrations of testosterone 
glucuronide, epitestosterone glucuronide and IS in blank plasma 
and urine over three concentration ranges using replicates of three 
samples. The samples consisted of blank plasma spiked with urine 
with 50 µL of β-glucuronidase added and incubated at 50°C for two 
hours. The samples were then cooled in wet ice prior to extraction. The 
concentration of testosterone and epitestosterone by de-conjugation 
was compared to samples spiked at the same concentration ranges with 
testosterone and epitestosterone and IS.
Analysis of testosterone and epitestosterone in rat serum and 
urine samples
Samples were prepared as previously described [15] and modified 
for serum and urine, by adding 100 µL of serum or urine to l mL of 
0.2 M pH 7 phosphate buffer. The sample was spiked with 50 µL of 
IS stanozolol-D3 to give a concentration of 2 ng/mL. The internal 
standard was used in order to compensate for variations in instrument 
injection to injection response and loss of analytes during the extraction 
procedure. 50 µL of β-glucuronidase enzyme was added and samples 
where incubated for two hours at 50°C. The samples were cooled on 
wet ice and extracted as described above.
Results and Discussion
Method validation
The validation results are within the limits set by FDA guidelines. 
Injection of blank samples of charcoal stripped plasma and urine 
confirmed no components of the matrices were observed that would 
interfere with the analytes. Figure 1 shows the chromatogram for 
extracted analytes in plasma and urine at 0.25 ng/mL.
The assay for urine analysis was linear for testosterone and 
epitestosterone between concentrations of 0.250 ng/mL-1000 ng/mL. 
Owing to the high range of standards low and high concentration 
calibrations curves were created for testosterone and epitestosterone. 
The determination coefficient (r2) values were at or above 0.9917 for 
testosterone and 0.9997 for epitestosterone in urine and r2 values were 
at or above 0.9919 for testosterone and 0.9997 for epitestosterone in 
plasma. Table 2 shows the accuracy, intra-day and inter-day precision 
results from the assay. The LLOQ for testosterone was found to be 
0.250 ng/mL for testosterone and 0.250 ng/mL for epitestosterone.
The plasma assay was linear between 0.250 ng/mL-1000 ng/mL for 
testosterone and epitestosterone. The method was capable of detecting 
testosterone and epitestosterone at LLOQ of 0.250 ng/mL. The LLOD 
for testosterone was 0.125 ng/mL and 0.250 ng/mL epitestosterone. The 
extraction recoveries for testosterone and epitestosterone are shown in 
Table 3.
Table 4 shows the comparisons from the plasma and urine matrix 
effects between samples of plasma that have been extracted and spiked 
with standard concentrations in acetonirile.
The deconjugation assay confirmed the β-glucuronidase enzyme 
was effective in de-conjugating testosterone and epitestosterone with 
the concentration and incubation for the concentrations shown in 
Table 5.
Application of method for determination of testosterone and 
epitestosterone in real samples of rat serum and urine
The validated method was applied to determine the total (free 
and de-glucuronidated) testosterone and epitestosterone in rat serum 
and urine samples. Table 6 shows the total analyte concentrations in 
a selection of rat urine samples. The average urinary testosterone and 
epitestosterone concentrations were 201.68 ± 90.16 ng/mL and 85.37 
± 21.20 ng/mL, respectively. The average ratio of concentrations of 
testosterone to epitestosterone in urine was 2.64 (range: 0.42-4.40).
 
Figure 1: Chromatograms of testosterone and epitestosterone from a) plasma and b) urine at 0.250 ng/mL LLOQ concentration level for epitestosterone.
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The results highlighted a variation in urinary testosterone and 
epitestosterone in rats. Albeit observed in a small sample, there were 
also variations in the ratios as the majority of rats had values higher 
than those which have been found in humans shown to be around a 
1:1 ratio with variations [16]. A number of factors could be considered 
for the variations in testosterone and epitestosterone concentrations 
between individual animals. One factor might be the alterations and 
differences in metabolic rate of these steroids. Another factor is possibly 
due to the amount of water consumed by the rats as this can change 
drug levels in the body. These variations, and the deviation from the 
ratio typically observed in humans can greatly affect clinical trials thus 
warrant attention.
Table 7 shows the testosterone and epitestosterone concentrations 
in the sera of six rats. The average concentration of testosterone was 
363.40 ± 11.615 ng/mL and epitestosterone was 1.75 ± 0.118 ng/mL. 
The average testosterone to epitestosterone ratio was 212.01 (range: 
161.54-230.69). The T/E ratio in the serum was a markedly higher 
than in urine owing to the high testosterone and low epitestosterone 
concentration in all animals. 
These results showed that there was less variation in concentration 
in the serum samples compared to the urine samples probably due to 
individual differences in water consumption. Previous methods have 
been reported but with limitations such as validated applications to 
either urine [17-20] or serum [21] only; and with an extraction method 
taking greater than 1 hour [21]. In comparison, the new method benefits 
from improved resolution [19] and the reduced requirement for 
Matrix Compound Concentration
(ng/mL)
Level Precision RSD (%) Accuracy 
(%)Intra-day
N=6
Inter-day
N=18
Urine
Testosterone
0.25 LLOQ 10.01 10.11 107.03
1.9 Low 2.66 5.51 96.61
15.6 Medium 4.20 10.29 104.02
250 High 1.13 3.39 97.11
Epitestosterone
0.25 LLOQ 1.25 9.56 100.50
1.9 Low 1.05 4.36 100.39
15.6 Medium 8.17 8.94 96.45
250 High 1.67 3.70 102.60
Plasma
Testosterone
0.25 LLOQ 8.14 8.21 109.14
1.9 Low 3.94 4.26 98.26
15.6 Medium 5.47 5.92 102.66
250 High 1.86 2.29 96.55
Epitestosterone
0.25 LLOQ 2.58 6.87 98.20
1.9 Low 1.44 2.96 103.01
15.6 Medium 7.05 6.50 98.29
250 High 1.82 3.19 100.86
Table 2: Inter-day and intra-day accuracy and precision for the detection of 
testosterone and epitestosterone in urine and plasma.
Matrix Compound Concentration 
(ng/mL)
% Extraction 
recovery (N=6)
Plasma
Testosterone
0.25 (LLOQ) 94.49
1 81.63
4 85.60
16 85.98
Epitestosterone
0.25 (LLOQ) 92.77
1 89.67
4 84.72
16 89.48
Urine
Testosterone
0.25 (LLOQ) 91.23
1 87.63
4 88.29
16 89.16
Epitestosterone
0.25 (LLOQ) 92.57
1 91.44
4 89.60
16 90.16
Table 3: Absolute extraction recovery results for testosterone and epitestosterone 
in plasma and urine.
Compound Concentration
(ng/mL)
Extracted 
plasma (ng/mL)
N=6
Extracted 
urine (ng/mL)
N=6
Standard in 
acetonitrile 
(ng/mL) N=6
Testosterone 0.25 (LLOQ) 0.248 0.241 0.250
1 0.977 0.952 0.957
2 2.019 2.005 2.053
8 8.089 8.129 8.455
Epitestosterone 1 1.002 1.094 0.992
2 2.051 1.961 1.977
8 8.038 8.122 8.110
Table 4: Matrix effect of plasma and urine on spiked testosterone and 
epitestosterone compared with standard concentrations in acetonitrile.
Matrix Compound Concentration
(ng/mL)
Extracted spiked 
steroid in matrix 
(ng/mL)
De-conjugated steroid 
concentration 
(ng/mL)
Urine
Testosterone
1 0.98 0.91
2 2.08 2.03
15 16.96 14.03
Epitestosterone
1 1.09 1.15
2 2.11 2.14
15 16.18 14.85
Plasma
Testosterone
1 1.02 1.09
2 2.04 2.07
15 15.81 15.29
Epitestosterone
1 1.08 0.96
2 1.97 1.94
15 15.87 15.06
Table 5: The concentration of testosterone and epitestosterone after de-conjugation 
by β-glucuronidase compared to standard concentrations of extracted testosterone 
and epitestosterone in plasma matrix.
Matrix Animal Testosterone Epitestosterone Ratio
Urine (ng/mL)
1 280.30 75.65 3.71
2 615.22 160.46 3.83
3 142.64 48.32 2.95
4 71.63 16.28 4.40
5 36.80 86.14 0.42
6 63.46 125.37 0.51
Average 201.68 ± 90.16 85.37 ± 21.20 2.64
Table 6: Concentrations of testosterone and epitestosterone in rat urine ± SEM of 
triplicate injections.
Matrix Animal Testosterone Epitestosterone Ratio
Serum (ng/ml)
1 386.39 ± 6.268 1.70 ± 0.286 227.89
2 378.84 ± 17.143 1.64 ± 0.129 230.69
3 318.52 ± 1.517 1.40 ± 0.025 227.12
4 381.15 ± 15.214 2.11 ± 0.065 180.26
5 378.80 ± 8.662 1.55 ± 0.028 244.54
6 336.70 ± 1.835 2.08 ± 0.063 161.54
Average 363.40 ± 11.615 1.75 ± 0.118 212.01
Table 7: Serum testosterone and epitestosterone in rats after the fourth week of 
sample collection ± SEM of triplicate injections.
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serum using liquid chromatography tandem mass spectrometry. Chem Cent 
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testosterone and epitestosterone in human hair using liquid chromatography-
tandem mass spectrometry. J Pharm Biomed Anal 67-68: 154-8.
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anabolic steroids in human hair using LC-MS/MS. Steroids 75: 710-714.
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Clin Chem 43: 1280-1288.
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in human urine using aqueous two-phase systems of ionic liquid and salt. J 
Chromatogr A 1082: 143-149.
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epitestosterone conjugates using high-performance liquid chromatography/
tandem mass spectrometry. J Mass Spectrom 35: 50-61.
19. Zhan Y, Musteata FM, Basset FA, Pawliszyn J (2011) Determination of free 
and deconjugated testosterone and epitestosterone in urine using SPME and 
LC-MS/MS. Bioanalysis 3: 23-30.
20. Levent A, Altun A, Yardim Y, Sentürk Z (2014) Sensitive voltammetric 
determination of testosterone in pharmaceuticals and human urine using a 
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Acta (In Press).
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chromatography-tandem mass spectrometry (LC-MS/MS) assay calibrated to 
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TD2004EAAS. Reporting and evaluation guidance for testosterone, 
epitestosterone, T/E ratio and other endogenous steroids.
sample volumes [20,21]. This report of a straightforward novel method 
of rapid analyses of testosterone and epitestosterone in both rat urine 
and sera benefits from a new rapid liquid-liquid extraction procedure, 
suitable for both biofluids. Unlike the predecessors, the proposed 
method streamlines experimental in vivo designs where simultaneous 
monitoring of testosterone and epitestosterone in both urine and blood 
is required, such as investigating the effect and consequences of altered 
metabolic function in testosterone and epitestosterone glucuronidation 
[7-10]. The new method also eliminates potential confounding effects 
from applying multiple methods to cater for multiple sample matrices.
Conclusions
A method has been described here for the validation and detection 
of the anabolic steroids testosterone and epitestosterone in rat serum 
and urine at low ng/mL concentrations using LC-MS/MS. This method 
shows optimal conditions for the de-conjugation of the steroid 
glucuronides to detect both free and conjugated steroids. In addition, 
this method has a good extraction recovery rate for both steroids 
allowing for accurate concentration determination by the use of the 
internal standard, stanozolol-D3.
Whilst methods have been described for the detection of 
testosterone and epitestosterone in humans [17,18], this method 
provides deconjugation and extraction procedures affording detection 
of testosterone and epitestosterone concentrations in rat serum and 
urine. This method could be used in future research to investigate 
testosterone and epitestosterone metabolism in vivo. Furthermore, 
it could also be extended to detect steroids in human serum and 
urine samples to confirm urinary levels of these compounds used in 
sports doping tests. This technique could also be applied to measure 
metabolism patterns of steroids in vivo in place of the current method 
used by WADA which specifies measurements acquired by gas 
chromatography tandem mass spectrometry [22]. An advantage is that 
the LC method could be incorporated into forensic toxicology software 
to take full advantage of drug testing by LC MS/MS.
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